메뉴 건너뛰기




Volumn 23, Issue 1, 2002, Pages 1-8

Development and validation of a non-linear IVIVC model for a diltiazem extended release Formulation

Author keywords

Convolution; Diltiazem; Dissolution; Prediction errors; Validation

Indexed keywords

DILTIAZEM; ETHYL CELLULOSE; WATER;

EID: 0036200128     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdd.270     Document Type: Article
Times cited : (47)

References (15)
  • 1
    • 0008679338 scopus 로고    scopus 로고
    • U.S. Department of Health, Food and Drug Administration Modified Release Solid Oral Dosage Form Guidance: Scale-up and Postapproval Changes: Chemistry, Manufacturing and Controls, In vitro Dissolution Testing and Bioequivalence Documentation. U.S. Department of Health, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), September
    • (1997)
  • 2
    • 0008673101 scopus 로고    scopus 로고
    • U.S. Department of Health, Food and Drug Administration. Guidance for the Industry: Extended Release Solid Oral Dosage Forms: Development, Evaluation and Application of In vitro/In vivo Correlations. U.S. and Drug Administration, Center for Drug Evaluation and Research (CDER), September
    • (1997)
  • 3
  • 12
    • 0033804946 scopus 로고    scopus 로고
    • Influence of stereoselective pharmacokinetics in the development and predictability of an IVIVC for the enantiomers of metoprolol tartrate
    • (2000) Pharm. Res , vol.17 , pp. 1019-1025
    • Sirisuth, N.1    Eddington, N.D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.